{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:55:32Z","timestamp":1782136532382,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["RCRDUN 2019 APP1199726"],"award-info":[{"award-number":["RCRDUN 2019 APP1199726"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health Disability and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care and Resuscitation"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ccrj.2026.100173","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:26:46Z","timestamp":1774373206000},"page":"100173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol summary and statistical analysis plan for the bone loss prevention with zoledronic acid or denosumab in critically ill adults (BONE ZONE) trial"],"prefix":"10.1016","volume":"28","author":[{"given":"Neil","family":"Orford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ary","family":"Serpa Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Bone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline R.","family":"Center","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Kotowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Litton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ccrj.2026.100173_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.201508-1514OC","article-title":"Changes in bone mineral density in the year after critical illness","volume":"193","author":"Orford","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccrj.2026.100173_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1097\/CCM.0b013e318211ff3d","article-title":"Skeletal morbidity among survivors of critical illness","volume":"39","author":"Orford","year":"2011","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100173_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13054-015-0892-y","article-title":"A pilot study of change in fracture risk in patients with acute respiratory distress syndrome","volume":"19","author":"Rawal","year":"2015","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.ccrj.2026.100173_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ccrj.2026.100173_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ccrj.2026.100173_bib6","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/jbmr.4694","article-title":"et al.,Denosumab for prevention of acute onset immobilization-induced alterations of bone turnover: a randomized controlled trial","volume":"37","author":"Wadiura","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100173_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-52607-1","article-title":"A pilot feasibility randomised controlled trial of bone antiresorptive agents on bone turnover markers in critically ill women","volume":"14","author":"Orford","year":"2024","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ccrj.2026.100173_bib8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2009-0852","article-title":"Effect of osteoporosis treatment on mortality: a meta-analysis","volume":"95","author":"Bolland","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"9992","key":"10.1016\/j.ccrj.2026.100173_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(15)60995-3","article-title":"Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo- controlled trial","volume":"386","author":"Gnant","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccrj.2026.100173_bib10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1210\/jc.2015-3467","article-title":"Preadmission bisphosphonate and mortality in critically ill patients","volume":"101","author":"Lee","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ccrj.2026.100173_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4158\/EP151050.OR","article-title":"Intravenous pamidronate is associated with reduced mortality in patients with chronic critical illness","volume":"22","author":"Schulman","year":"2016","journal-title":"Endocr Pract\u202f: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100173_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-017-1657-6","article-title":"The association of time and medications with changes in bone mineral density in the 2 years after critical illness","volume":"21","author":"Orford","year":"2017","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccrj.2026.100173_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0885066611402156","article-title":"Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness","volume":"27","author":"Via","year":"2012","journal-title":"J Intensive Care Med"},{"issue":"5","key":"10.1016\/j.ccrj.2026.100173_bib14","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.2025.4486","article-title":"SPIRIT 2025 statement","volume":"334","author":"Chan","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.ccrj.2026.100173_bib15","author":"Council"},{"issue":"C","key":"10.1016\/j.ccrj.2026.100173_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2015.03.004","article-title":"FRAX (Aus) and falls risk: association in men and women","volume":"76","author":"Holloway","year":"2015","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ccrj.2026.100173_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/cc2872","article-title":"Acute renal failure \u2013 definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"}],"container-title":["Critical Care and Resuscitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1441277226000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1441277226000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:13:53Z","timestamp":1782134033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1441277226000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1441277226000128"],"URL":"https:\/\/doi.org\/10.1016\/j.ccrj.2026.100173","relation":{},"ISSN":["1441-2772"],"issn-type":[{"value":"1441-2772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol summary and statistical analysis plan for the bone loss prevention with zoledronic acid or denosumab in critically ill adults (BONE ZONE) trial","name":"articletitle","label":"Article Title"},{"value":"Critical Care and Resuscitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccrj.2026.100173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of College of Intensive Care Medicine of Australia and New Zealand.","name":"copyright","label":"Copyright"}],"article-number":"100173"}}